Heart Type Fatty Acid Binding Protein In Patients With Acute Coronary Syndrome Research Progress

【Abstract】Acute Coronary Syndrome(ACS) is a major reason of causing death tohuman.To early calculate and prevent the rate of progress is important to cut down theproportion of deformity and death.A sensitive and specific markers of myocardial injuryin coronary heart disease diagnosis abnormal changes as acute onset of necessaryconditions, early onset it changes can be rapid diagnosis, timely access to the rapidtreatment of channel, it is to reduce the mortality and improve the prognosis ofcritical.Heart-type fatty acid-binding protein(H-FABP) that is a test to detect myocardialdamage with Small molecular weight and higher specificity of myocardium havemore sensitivity and specificity in diagnosis of early ACS,Compared with the traditional,creatine kinase isoenzymes of creatine kinase, cardiac troponin I, troponin T, myoglobinand cardiac markers,it may has great potential as an excellent biochemical cardiacmarker for diagnosis of ACS in early phase,and improve the level of the preciseness andseasonable in diagnosis myocardial injury.If the heart-type fatty acid binding proteinand traditional, creatine kinase isoenzymes of creatine kinase, cardiac troponin I,troponin T, myoglobin contact applications, will be to save the patients with acutecoronary syndrome have some clinical significance.